avapro has been researched along with Cholestasis in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Cholestasis: Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, RJ | 1 |
| Lucena, MI | 1 |
| Fernández, MC | 1 |
| Vega, JL | 1 |
| García-Cortés, M | 1 |
| Casado, M | 1 |
| Guerrero-Sanchez, E | 1 |
| Pulido-Fernandez, F | 1 |
1 review available for avapro and Cholestasis
| Article | Year |
|---|---|
Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of angiotensin II antagonist-associated hepatotoxicity.
Topics: Acute Disease; Biopsy, Needle; Biphenyl Compounds; Chemical and Drug Induced Liver Injury; Cholestas | 2002 |